The Original Investigation titled “Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Open-Label Trial,”1 published on December 6, 2023, was corrected to revise the study type in the title and text from “a nonrandomized controlled trial” to “a nonrandomized open-label trial.” This article was corrected online.
1.Aaronson
ST, van der Vaart
A, Miller
T,
et al. Single-dose synthetic psilocybin with psychotherapy for treatment-resistant bipolar type II major depressive episodes: a nonrandomized open-label trial.
JAMA Psychiatry. Published online December 6, 2023. doi:
10.1001/jamapsychiatry.2023.4685Google ScholarCrossref